2022
DOI: 10.1111/trf.16809
|View full text |Cite
|
Sign up to set email alerts
|

The timing of gamma irradiation and its effect on cell‐free and microvesicle‐bound hemoglobin. The BEST collaborative study

Abstract: Funding informationCanadian Blood Services is funded by the federal government (Health Canada) and provincial and territorial ministries of health.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 23 publications
(44 reference statements)
0
3
0
Order By: Relevance
“…The impact of the timing of irradiation is controversial. Although sREV release did not significantly vary with timing of irradiation in one report [20 ▪ ], both X and gamma irradiation induced a higher sREV generation in PRBCs that were older at the time of irradiation or were stored for longer postirradiation periods in another study [21].…”
Section: Generation and Characterization Of Stored Red Cell Derived E...mentioning
confidence: 91%
See 1 more Smart Citation
“…The impact of the timing of irradiation is controversial. Although sREV release did not significantly vary with timing of irradiation in one report [20 ▪ ], both X and gamma irradiation induced a higher sREV generation in PRBCs that were older at the time of irradiation or were stored for longer postirradiation periods in another study [21].…”
Section: Generation and Characterization Of Stored Red Cell Derived E...mentioning
confidence: 91%
“…PRBC units may be irradiated to prevent graft-versus-host disease in high-risk recipient populations. In addition to increasing the hemolysis rate, both X and gamma irradiation may similarly increase sREV release [19][20][21]. The impact of the timing of irradiation is controversial.…”
Section: Influence Of Pretransfusion Processingmentioning
confidence: 99%
“…Biochemical compounds and biological complexes in transfused blood products can lead to non‐infectious adverse effects in susceptible recipients 47 . Therefore, understanding mechanisms for how blood products, and compounds found therein interact with recipient cells and organ systems; and use of novel strategies to prevent occurrence of the “wrong” product being transfused into the “right” recipient or the “right” product transfused to the “wrong” recipient are important to advancing blood safety 48,49 . Research to define exposure limits and standards for concentrations of potentially harmful compounds and methods to improve blood safety by reducing errors in all steps of the transfusion process are still needed.…”
Section: Research Prioritiesmentioning
confidence: 99%